Allarity Therapeutics, Inc. (ALLR) vs Marker Therapeutics, Inc. (MRKR)
A side-by-side comparison of Allarity Therapeutics, Inc. and Marker Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALLR
Allarity Therapeutics, Inc.
$0.99HealthcareDelayed quote: Oct 6, 2026, 11:34 AM EDT
MRKR
Marker Therapeutics, Inc.
$1.04HealthcareDelayed quote: Oct 6, 2026, 11:33 AM EDT
Total return — ALLR vs MRKR
growth of $100 · dividends reinvested · last 5yALLR -100.0% (-95.9%/yr)MRKR -89.1% (-35.8%/yr)MRKR compounded faster over this window
Log scale — wide-divergence pair
ALLR MRKR
ALLR vs MRKR: by the numbers
- •MRKR is the larger company ($17M vs $16M market cap).
- •Both run net losses; MRKR's is the smaller (-706.23% vs -3575.07% net margin).
Metrics side by side
Valuation
| Metric | ALLR | MRKR |
|---|---|---|
| P/S ratio | 45.88 | 14.06 |
| P/B ratio | 4.48 | 1.43 |
Profitability
| Metric | ALLR | MRKR |
|---|---|---|
| Gross margin | 107.54% | 0.00% |
| Operating margin | -3939.06% | 0.00% |
| Net margin | -3575.07% | -706.23% |
| ROE | -348.81% | -71.57% |
| ROIC | -41.81% | -88.07% |
Growth (annualized)
| Metric | ALLR | MRKR |
|---|---|---|
| Total return CAGR (5Y) | N/A | -42.13% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.